Switching Off Cancer-Causing Telomerase Using Small Molecules.

Area of Science:

• Oncology
• Molecular Biology
• Chemical Biology

Background:

• Aberrant telomerase activity, driven by human telomerase reverse transcriptase (hTERT), is a characteristic of many malignant cancers.
• Targeting telomerase offers a promising strategy for cancer therapy.

Purpose of the Study:

• To investigate the potential of small molecules to downregulate hTERT expression.
• To explore a novel therapeutic approach by targeting a repressive DNA motif on the hTERT gene promoter.

Main Methods:

• Utilized small molecules designed to interact with a specific repressive DNA motif on the hTERT gene promoter.
• Assessed the effect of these small molecules on hTERT expression and telomerase activity.
• Evaluated the impact of hTERT downregulation on cancer cell viability.

Main Results:

• Demonstrated successful downregulation of hTERT expression using targeted small molecules.
• Showcased effective inhibition of telomerase activity through promoter targeting.
• Confirmed significant cancer cell death upon hTERT downregulation.

Conclusions:

• Small molecule-mediated targeting of the hTERT promoter is a viable strategy for cancer treatment.
• Downregulation of hTERT effectively eliminates cancer cells by inhibiting telomerase.
• This approach presents a novel therapeutic avenue for managing malignant cancers.